BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7872590)

  • 1. Mammographic screening for women aged 40 to 49 years: the primary care practitioner's dilemma.
    Sickles EA; Kopans DB
    Ann Intern Med; 1995 Apr; 122(7):534-8. PubMed ID: 7872590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
    Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
    AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammography in symptomatic and asymptomatic patients.
    Stomper PC; Gelman RS
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammography outcomes in a practice setting by age: prognostic factors, sensitivity, and positive biopsy rate.
    Linver MN; Paster SB
    J Natl Cancer Inst Monogr; 1997; (22):113-7. PubMed ID: 9709286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammographic screening in older women. Is it worthwhile?
    van Dijck JA; Broeders MJ; Verbeek AL
    Drugs Aging; 1997 Feb; 10(2):69-79. PubMed ID: 9061265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
    de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
    J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation.
    Nelson HD; Fu R; Cantor A; Pappas M; Daeges M; Humphrey L
    Ann Intern Med; 2016 Feb; 164(4):244-55. PubMed ID: 26756588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival advantage differences by age. Evaluation of the extended follow-up of the Breast Cancer Detection Demonstration Project.
    Byrne C; Smart CR; Chu KC; Hartmann WH
    Cancer; 1994 Jul; 74(1 Suppl):301-10. PubMed ID: 8004601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encouraging attendance at screening mammography: knowledge, attitudes and intentions of general practitioners.
    Cockburn J; Irwig L; Turnbull D; Simpson JM; Mock P; Tattersall M
    Med J Aust; 1989 Oct; 151(7):391-6. PubMed ID: 2796815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammographic screening of women aged 40 to 49 years. Is it justified?
    Feig SA
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive predictive value of screening mammography by age and family history of breast cancer.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
    JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening mammography: value in women 35-39 years old.
    Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS
    AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer screening outcomes in women ages 40-49: clinical experience with service screening using modern mammography.
    Sickles EA
    J Natl Cancer Inst Monogr; 1997; (22):99-104. PubMed ID: 9709284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of screening mammography. A meta-analysis.
    Kerlikowske K; Grady D; Rubin SM; Sandrock C; Ernster VL
    JAMA; 1995 Jan; 273(2):149-54. PubMed ID: 7799496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammography in 40-year-old women: what difference does it make? The potential impact of the U.S. Preventative Services Task Force (USPSTF) mammography guidelines.
    Shen N; Hammonds LS; Madsen D; Dale P
    Ann Surg Oncol; 2011 Oct; 18(11):3066-71. PubMed ID: 21863364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.